Mini-kidneys to test a drug to stop Covid-19
Search Results for:
Nuria Montserrat, principal investigator of the “Pluripotency for organ regeneration” and her group have participated in an international study to find a treatment to stop the virus from continuing infecting other cells, preventing the virus from replicating.Junior Group Leader position within the BIST- la Caixa initiative in Chemical Biology
Application Deadline: 31/05/2020
Postdoctoral and senior researchers with excellent scientific record in the topic Chemical Biology are invited to apply for a Junior Group Leader position in IBEC’s non-tenure-track open call for 2020.
Junior Group Leader position within the BIST- la Caixa initiative in Chemical Biology
Application Deadline: 31/05/2020
Postdoctoral and senior researchers with excellent scientific record in the topic Chemical Biology are invited to apply for a Junior Group Leader position in IBEC’s non-tenure-track open call for 2020.
Junior Group Leader position within the BIST- la Caixa initiative in Chemical Biology
Application Deadline: 31/05/2020
Postdoctoral and senior researchers with excellent scientific record in the topic Chemical Biology are invited to apply for a Junior Group Leader position in IBEC’s non-tenure-track open call for 2020.
Researchers at IBEC help identifying a drug in clinical phase that blocks the effects of SARS-Co-V2
IBEC researchers led by ICREA Research Professor Núria Montserrat, together with international collaborators, have identified a drug capable of blocking the effects of the SARS-Co-V2 virus, the origin of the Coronavirus 2019 disease.
IBEC researchers led by ICREA Research Professor Núria Montserrat, together with international collaborators, have identified a drug capable of blocking the effects of the SARS-Co-V2 virus, the origin of the Coronavirus 2019 disease.The treatment, which can be tested on two hundred Covid-19 patients as of today, has proven effective in mini-kidneys generated from human stem cells. Using hese organoids generated by bioengineering techniques, it has been deciphered how SARS-Co-V2 interacts and infects human kidney cells.
Junior Group Leader position within the BIST- la Caixa initiative in Chemical Biology
Postdoctoral and senior researchers with excellent scientific record in the topic Chemical Biology are invited to apply for a Junior Group Leader position in IBEC’s non-tenure-track open call for … Read more
IBEC in the catalan TV news
IBEC appears on the catalan news on TV3, where they summarise the various Catalan initiatives to fight against Covid-19.
IBEC appears on the catalan news on TV3, where they summarise the various Catalan initiatives to fight against Covid-19.The European Research Council awards funding to 10 projects in Catalonia
Several media channels have reported this year’s European Research Council grants to various projects being undertaken in Catalonia. Among these projects is that of Xavier Trepat, group leader at IBEC.
Several media channels have reported this year’s European Research Council grants to various projects being undertaken in Catalonia. Among these projects is that of Xavier Trepat, group leader at IBEC.The European Research Council awards funding to 10 projects in Catalonia
Several media channels have reported this year’s European Research Council grants to various projects being undertaken in Catalonia. Among these projects is that of Xavier Trepat, group leader at IBEC.
Xavier Trepat receives the ERC Advanced Grant to lay the basis of a new generation of biological robots
The researcher at the Institute for Bioengineering of Catalonia (IBEC), Xavier Trepat, has received the prestigious ERC Advanced Grant awarded by the European Research Council (ERC) worth 2.5 million euros.
Thanks to this grant the expert and his group will be able to study the mechanical properties of the epithelium in 3D and to lay the foundations for a pioneering technology called “Epifluidics”, which will allow the design of biological robots.